PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
 
Neurosci Lett. Dec 10, 2010; 486(2-13): 78–83.
PMCID: PMC2977848
The trafficking of NaV1.8
Richard S. Swanwick, Alessandro Pristerá, and Kenji Okuse[low asterisk]
Division of Cell & Molecular Biology, Imperial College London, London SW7 2AZ, UK
Kenji Okuse: k.okuse/at/imperial.ac.uk
[low asterisk]Corresponding author. k.okuse/at/imperial.ac.uk
Received June 25, 2010; Revised August 24, 2010; Accepted August 25, 2010.
This document was posted here by permission of the publisher. At the time of the deposit, it included all changes made during peer review, copy editing, and publishing. The U. S. National Library of Medicine is responsible for all links within the document and for incorporating any publisher-supplied amendments or retractions issued subsequently. The published journal article, guaranteed to be such by Elsevier, is available for free, on ScienceDirect, at: http://dx.crossref.org/10.1016/j.neulet.2010.08.074
Research highlights
[triangle] The β3 subunit masks the ER retention signal of NaV1.8 and release the channel from the ER. [triangle] p11 directly binds to NaV1.8 and help its translocation to the plasma membrane. [triangle] PDZD2 is responsible for the functional expression of NaV1.8 on the plasma membrane. [triangle] Contactin KO mice exhibit a reduction of NaV1.8 along unmyelinated axons in the sciatic nerve. [triangle] PKA activation increases the NaV1.8 density on the membrane through direct phosphorylation.
Keywords: Sodium Channel, Sensory Neuron, Pain, Trafficking
Abstract
The α-subunit of tetrodotoxin-resistant voltage-gated sodium channel NaV1.8 is selectively expressed in sensory neurons. It has been reported that NaV1.8 is involved in the transmission of nociceptive information from sensory neurons to the central nervous system in nociceptive [1] and neuropathic [24] pain conditions. Thus NaV1.8 has been a promising target to treat chronic pain. Here we discuss the recent advances in the study of trafficking mechanism of NaV1.8. These pieces of information are particularly important as such trafficking machinery could be new targets for painkillers.
Keywords: Sodium Channel, Sensory Neuron, Pain, Trafficking
Membrane proteins are translated in the rough ER, post-translationally modified and sorted during their migration through the Golgi to the plasma membrane. Interestingly, a large sub-population of voltage-gated sodium channels are not directly translocated to the plasma membrane, but stored in a metabolically stable ‘intracelluar pool’ of folded protein [36]. This pool may permit the neuron to respond rapidly to stimuli, allowing it to increase channel surface density faster than de novo synthesis would otherwise allow. Recent reports describe many novel mechanisms which regulate the trafficking of ion channels to the plasma membrane occurring at many points along the pathway including the initial translation and folding, subsequent post-translational modification e.g. N-glycosylation and palmitylation and by numerous protein–protein interactions.
The RXR motif, which serves as an ER retention signal, is found in many membrane proteins, including ATP-sensitive potassium channels [53], NMDA [40] and GABAB receptors [12]. NaV1.8 possesses at least one functional ER retention signal within the first intracellular loop, consisting of residues RRR495–497 [54]. Substitution of this motif with alanines results in an increased expression of the channel on the membrane. The mechanism behind NaV1.8 release from the ER and trafficking to the cell surface has been described. The auxiliary β3 subunit, which is expressed in dorsal root ganglia (DRG) neurons, associates with the α-subunit of voltage-gated sodium channels [48], and plays a key role in this process. The intracellular C-terminus of the β3 subunit directly binds the portion of NaV1.8 containing the RRR signal [54] (Fig. 1). This interaction masks the retention signal and leads to the release of the channel from the ER. Other sodium channels also contain potential ER retention signals, although the position of this motif is not conserved (e.g. NaV1.5 – RKR amino acid 480–482). Hence, similar mechanisms to control retention/trafficking to the membrane could exist for the other sodium channel isoforms. It is known the β3 subunit is up-regulated in small diameter neurons upon nerve axotomy [48], chronic constriction injury [41] and, in medium size neurons, in diabetic neuropathy models [42]. Thus, the β3 subunit mediated NaV1.8 release from the ER could also account for increased excitability in pain states due to additional NaV1.8 being transported onto the cell membrane.
Fig. 1
Fig. 1
Structure of the NaV1.8 showing the four homologous domains, each of which is composed of six membrane spanning segments. The S4 voltage sensors are shown in pink. The binding sites for the NaV1.8-interacting proteins are shown. The five sites for PKA (more ...)
Although the β3 subunit has been shown to help translocation of NaV1.8 from ER to the plasma membrane as described above, we found that co-expression of accessory β-subunits did not help the functional NaV1.8 expression in heterologous cells such as COS [3]. This suggested that NaV1.8 requires other accessory proteins for its functional expression on the plasma membrane and led to the discovery of p11 as a novel permissive factor for NaV1.8 [32]. p11 (S100A10, Annexin 2 light chain) is a member of the S100 calcium binding protein family, which regulates many cellular processes in response to intracellular calcium changes. p11 is expressed in a large number of tissues and is present in many regions of the CNS including the cerebral cortex, hippocampus and hypothalamus [38,55]. It exists as a tight, non-covalent dimer and is the only member of family to have suffered mutations within its EF hand motifs, rendering it Ca2+ insensitive [19]. Although p11 cannot respond to calcium fluctuations, it exists in a permanently “activated state” compared to other members of the S100 family [18]. The majority of p11 present intracellularly, exists as a heterotetramer (A2t), composed of two identical annexin II heavy chains [19]. Annexin II, interacts in a Ca2+-dependent manner with negatively charged phospholipids, also binding to cholesterol and many protein ligands including actin, and is thought to be involved in many membrane-related events including endosome membrane trafficking along the recycling and degradation pathways [23,2]. The phosphorylation by PKC of Ser11 of Annexin II disrupts p11 binding [20], while the activation of a protein phosphatase by PKA and subsequent dephosphorylation of the same residue [34] may allow coupling of the p11 localisation to the Ca2+ and cAMP-dependent cellular signalling pathways.
Both yeast two-hybrid and GST pull-down assays demonstrate that p11 binds to the amino terminus of NaV1.8, especially resides 74–103, located close to the start of the initial transmembrane domain [30] (Fig. 1). Upon co-expression of p11 with NaV1.8 in heterologous cells such as CHO, the channel successfully translocated to the plasma membrane [32] (Fig. 2), even in the absence of additional β-subunits. In DRGs, in the absence of p11 (DRG specific knock-out), poor functional NaV1.8 expression is observed [9]. Interestingly, since functional expression is not totally abolished in the knock-out, additional factors expressed specifically by neurons, may be capable of trafficking a small amount of the channel. Significantly, p11 binds only to NaV1.8 and not to the other sodium channel subtypes also expressed in nociceptive neurons, such as NaV1.7 and NaV1.9 [33].
Fig. 2
Fig. 2
(a) NaV1.8-like immunoreactivity in CHO-SNS22 cells. (b) Transient expression of GFP-p11 fusion protein in CHO-SNS22 cell. (c) Merged picture of (a) and (b) showing co-expression of p11 and NaV1.8 in the plasma membrane. (d and e) Microscopic images were (more ...)
Reproduced, with permission, from Ref. [32].
The identification of p11 as a chaperone protein for NaV1.8 has been followed by discoveries of many other membrane proteins controlled by p11 including TASK-1, 5-HT1B receptors, ASIC-1, TrpV5, and TrpV6. p11 promotes the membrane localisation of TASK-1 by masking an ER retention signal at the end of the C-terminal of the channel [13]. Interestingly p11 has also been reported to act as an ER retention factor by binding to the other region of the C-terminal of TASK-1 [35]. At present the ability of p11 to act either ER retention factor or translocation promoter with different proteins is not understood. There is evidence to suggest that the carboxy terminus of p11 itself, may contain an ER retention motif, and thus interaction with other proteins may subsequently lead to ER retention [35]. Additionally, p11 could itself interact with other proteins masking their ER retention motifs, blocking their effect and subsequently releasing the protein from the ER.
PDZD2, also known as Papin, AIPC and PDZK3, is a large protein (2766 amino acid), which was identified as an interactor of NaV1.8 using the yeast two-hybrid system [30]. PDZD2 contains six PDZ domains, four located at the N-terminus and two at the C-terminus, and is thought to act as a scaffolding protein assisting the trafficking and/or clustering of target proteins [22]. PDZD2 is expressed in several tissues including heart, lung, pancreas and DRG [52]. In DRGs, PDZD2 is expressed in both small peripherin positive and large NF200 positive neurons [44]. PDZD2 has been shown to directly bind the second intracellular loop of NaV1.8 (between domain II and III) through its C-terminus (Fig. 1). Antisense mRNA and siRNA mediated knock-down of PDZD2 in DRG neurons in vitro leads to a drastic reduction of NaV1.8 mediated sodium currents [44] (Fig. 3). Whether PDZD2 regulates the trafficking or the retention of NaV1.8 within the membrane has not yet been addressed. PDZD2 has also been shown to bind NaV1.7 and, may bind to all voltage-gated sodium channels via conserved PDZ binding motifs [44,45]. The binding of PDZD2 to NaV1.8 and NaV1.7 (which together underlie action potential generation and propagation in unmyelinated nociceptive fibres) suggests that PDZD2 may modulate cell excitability and ultimately pain thresholds. The role of PDZD2 in pain sensitivity has been investigated in PDZD2 knock-out mice, however no alterations in pain behaviours were observed (mechanical, thermal and inflammatory pain models) [44]. The absence of a pain phenotype could be explained by the up-regulation of p11 that occurs in these mice, which could mask PDZD2 effects by increasing the amount of membrane associated NaV1.8 [44]. Interestingly, the assumption that NaV1.8 is solely expressed in DRG has been challenged by the discovery that both mouse and human atria and ventricles contain mRNA for NaV1.8 and significantly a mutation in the channel is linked to cardiac problems [6]. This mutation V1073A in the second intracellular loop of NaV1.8, is flanked by a putative phosphorylation site (RKDS) and a class I PDZ binding motif. As both PDZD2 and syntrophin-associated serine/threonine kinase (SASTK) have been shown to bind this intracellular loop [30] (Fig. 1), interaction with these molecules may be linked to the trafficking and electrophysiological properties of NaV1.8.
Fig. 3
Fig. 3
(a) PDZD2 antisense mRNA expression in DRG neurons caused a loss of NaV1.8 current density. (b) Transfection of PDZD2-specific siRNA (conjugated to Alexa Fluor-488) into cultured DRG neurons caused efficient and specific down-regulation of endogenous (more ...)
Reproduced, with permission, from Ref. [44].
Contactin is a glycosyl-phosphatidylinositol-anchored CAM protein expressed by neurons. Reports show that it co-immunoprecipitates with sodium channels from the brain and enhances NaV1.2 currents when co-expressed with β1 subunit in a heterologous system [21]. Also, the interaction between Contactin, β1 subunit, and Ankyrin is required to keep NaV1.2 at high density on the cell membrane [28]. Further to this, Contactin binds to NaV1.3, resulting in increased sodium peak currents without changing the electrophysiological properties of the channel [43]. In addition, Contactin regulates NaV1.8 and NaV1.9 mediated currents [37]. In Contactin knock-out mice, tetrodotoxin-resistant currents are decreased while tetrodotoxin-sensitive currents are unaltered in unmyelinated DRG neurons. In these animals the NaV1.8 activation curve was shifted to a more depolarised potential (i.e. a greater depolarisation is needed for activation) but no changes were apparent for NaV1.9. Contactin deficient mice also exhibit a reduction of NaV1.8 and NaV1.9 (but not of NaV1.6 and NaV1.7) immunoreactivity along unmyelinated axons in the sciatic nerve, suggesting a role of Contactin in regulating the surface expression of these channels.
It is well established that during inflammatory conditions several compounds such as prostaglandin E2 (PGE2), adenosine triphosphate, Bradykinin, nerve growth factor and histamine activate intracellular cascades resulting in sensitisation of nerve terminals and lowered pain thresholds. Among these compounds, PGE2, a derivate of arachidonic acid, binds to its receptors, EP2 and EP4, which in turn activate intracellular Protein kinase A (PKA) (reviewed in Refs. [31,25]). PKA phosphorylates serine residues within the intracellular loop I of NaV1.8 and alters its gating properties, shifting its steady-state activation curve to a more negative potential [8] (Fig. 4). This change may account for an increase in NaV1.8 mediated sodium currents and higher cell excitability. However, increased trafficking of NaV1.8 to the cell membrane has recently been discovered to substantially contribute to this phenomenon [27]. It has been demonstrated that PGE2 directly promotes surface expression of NaV1.8 in a dose-dependent manner, and this effect can be blocked by cellular trafficking inhibitors. Forskolin, an activator of PKA, increases the NaV1.8 density on the membrane and mutation of the phosphorylation sites (RXXS) on NaV1.8 abolishes forskolin mediated effects. Interestingly, this effect of PKA phosphorylation is dependent on the ER retention motif RRR (whose sequence is shared with a phosphorylation site), but is independent of the masking effect of the β3 subunit mentioned above.
Fig. 4
Fig. 4
Comparison of voltage-dependence of current activation in wild-type NaV1.8 (WT) and the mutant NaV1.8 (SA) which lacks five PKA consensus phosphorylation sites within the intracellular loop between domain I and II. Representative currents and associated (more ...)
Reproduced, with permission, from Ref. [8].
Endocytosis is known to regulate the surface presentation of many membrane proteins. Sodium channels have been demonstrated to be selectively degraded in acidic/lysosomal vesicles upon infection of DRG neurons by herpes simplex virus [47]. Using the C-terminus of NaV1.8 as bait in yeast two-hybrid screens, CAP-1A (Clathrin-associated protein-1A) was identified as a binding partner [26]. CAP-1A is thought to bind to a conserved motif also present in other sodium channels such NaV1.2 [11] and act as an adaptor protein, linking voltage-gated sodium channels to clathrin, which is involved in coated vesicle assembly. Calmodulin binding to an IQ motif within the C-terminus has been proposed to disrupt CAP-1A binding and subsequently inhibit its cell surface removal by the endocytic pathway [7].
There is a growing body of evidence suggesting that local translation, where transcription is distal from the final location of protein synthesis, is an important mechanism regulating many cellular functions. mRNA transportation, localisation and subsequent “local translation” is thought to be especially important in highly polarised cells, including neurons, where a rapid response to stimuli would be limited by long distance protein transport. In neuronal cells, it has been demonstrated to play a role in axonal growth [29], long-term potentiation in the brain [5], synaptic plasticity [51] and to modulate pain threshold [17]. At present, “local synthesis” of transmembrane proteins is controversial as their synthesis and post-translational modifications (e.g. glycosylation) requires both ER and Golgi at the location of synthesis, although tantalising evidence suggests that some membrane proteins can be synthesised locally such as GluR and IP3RI, where these membrane proteins are expressed along dendrites and at the synapses respectively [46,15].
A recent study has investigated the potential involvement of local translation on NaV1.8 protein changes in a model on neuropathic pain [50]. Upon sciatic nerve entrapment it has been found that compound action potential and NaV1.8 immunoreactivity increased in the treated nerve. Concomitant with these findings, NaV1.8 mRNA level was up-regulated in the sciatic nerve but remained unchanged in the DRG, while no changes were detected for the mRNAs of other channel isoforms. It has been proposed that specific and enhanced transport of NaV1.8 mRNA into the axons may account for this up-regulation and that local mRNA accumulation could contribute to increased axonal NaV1.8 protein levels. Recent evidence using rapamycin inhibition of mTOR suggests that, in DRG, Aδ but not C-fibre neurons contain the machinery to carry out local translation [17]. Interestingly, a small subset of C-fibres may indeed be capable of local translation, although more work needs to be carried out to confirm this result. A recent study measuring the axonal transport velocity of Kv1.2 recorded a rate of 0.8 μm/s [14]. Assuming this velocity is similar for sodium channels, the transport of molecules to the extreme ends of the axon may require many days. Plasma membrane inserted sodium channels exhibit a half-life of around 50 h and those within the intracellular pool significantly less (~30 h) [39]. These values place an upper limit on the distance the channels could diffuse or be actively transported to their destination.
Because of its involvement in pain pathways and tissue-specific localisation, NaV1.8 has been one of the best studied sodium channels and expected to be a good target for the treatment of chronic pain. Although many attempts have been made to develop specific blockers for NaV1.8 [10,16], the development of type-specific blockers of individual sodium channels has remained challenging due to the similarities among the sodium channels. Successful use of gabapentin/pregabalin for the treatment of neuropathic pain provided a new route to block channel activities, i.e. targeting accessory subunits to inhibit the localisation of calcium channels to the plasma membrane and/or to alter the activation kinetics [49]. The trafficking mechanisms of NaV1.8 discussed above may provide such novel targets for the treatment of chronic pain.
1. Akopian A.N., Souslova V., England S., Okuse K., Ogata N., Ure J., Smith A., Kerr B.J., McMahon S.B., Boyce S., Hill R., Stanfa L.C., Dickenson A.H., Wood J.N. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat. Neurosci. 1999;2(6):541–548. [PubMed]
2. Babiychuk E.B., Draeger A. Annexins in cell membrane dynamics: Ca2+-regulated association of lipid microdomains. J. Cell Biol. 2000;150(5):1113–1123. [PMC free article] [PubMed]
3. Baker M.D., Poon W.-Y.L., Wood J.N., Okuse K. Functional effects of co-transfecting β-subunits 1, 1A and 3 with NaV1. 8 α-subunit in a COS-7 heterologous system. J. Physiol. 2004;555P:PC20.
5. Bramham C.R., Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 2005;76(2):99–125. [PubMed]
6. Chambers J.C., Zhao J., Terracciano C.M., Bezzina C.R., Zhang W., Kaba R., Navaratnarajah M., Lotlikar A., Sehmi J.S., Kooner M.K., Deng G., Siedlecka U., Parasramka S., El-Hamamsy I., Wass M.N., Dekker L.R., de Jong J.S., Sternberg M.J., McKenna W., Severs N.J., de Silva R., Wilde A.A., Anand P., Yacoub M., Scott J., Elliott P., Wood J.N., Kooner J.S. Genetic variation in SCN10A influences cardiac conduction. Nat. Genet. 2010;42(2):149–152. [PubMed]
7. Choi J.S., Hudmon A., Waxman S.G., Dib-Hajj S.D. Calmodulin regulates current density and frequency-dependent inhibition of sodium channel Nav1.8 in DRG neurons. J. Neurophysiol. 2006;96:97–108. [PubMed]
8. Fitzgerald E.M., Okuse K., Wood J.N., Dolphin A.C., Moss S.J. cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS. J. Physiol. 1999;516(Pt 2):433–446. [PubMed]
9. Foulkes T., Nassar M.A., Lane T., Matthews E.A., Baker M.D., Gerke V., Okuse K., Dickenson A.H., Wood J.N. Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behaviour. J. Neurosci. 2006;26(41):10499–10507. [PubMed]
10. Gaida W., Klinder K., Arndt K., Weiser T. Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. Neuropharmacology. 2005;49(8):1220–1227. [PubMed]
11. Garrido J.J., Fernandes F., Giraud P., Mouret I., Pasqualini E., Fache M.P., Jullien F., Dargent B. Identification of an axonal determinant in the C-terminus of the sodium channel Na(v)1.2. EMBO J. 2001;20(21):5950–5961. [PubMed]
12. Gassmann M., Haller C., Stoll Y., Aziz S.A., Biermann B., Mosbacher J., Kaupmann K., Bettler B. The RXR-type endoplasmic reticulum-retention/retrieval signal of GABAB1 requires distant spacing from the membrane to function. Mol. Pharmacol. 2005;68(1):137–144. [PubMed]
13. Girard C., Tinel N., Terrenoire C., Romey G., Lazdunski M., Borsotto M. p11, an annexin II subunit, an auxiliary protein associated with the background K+ channel, TASK-1. EMBO J. 2002;21(17):4439–4448. [PubMed]
14. Gu Y, Gu C. Dynamics of Kv1 channel transport in axons. PLoS One. 2010;5(8):e11931. [PMC free article] [PubMed]
15. Iijima T., Imai T., Kimura Y., Bernstein A., Okano H.J., Yuzaki M., Okano H. Hzf protein regulates dendritic localization an BDNF-induced translation of type 1 inositol 1,4,5-trisphosphate receptor mRNA. Proc. Natl. Acad. Sci. U. S. A. 2005;102(47):17190–17195. [PubMed]
16. Jarvis M.F., Honore P., Shieh C.C., Chapman M., Joshi S., Zhang X.F., Kort M., Carroll W., Marron B., Atkinson R., Thomas J., Liu D., Krambis M., Liu Y., McGaraughty S., Chu K., Roeloffs R., Zhong C., Mikusa J.P., Hernandez G., Gauvin D., Wade C., Zhu C., Pai M., Scanio M., Shi L., Drizin I., Gregg R., Matulenko M., Hakeem A., Gross M., Johnson M., Marsh K., Wagoner P.K., Sullivan J.P., Faltynek C.R., Krafte D.S. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc. Natl. Acad. Sci. U. S. A. 2007;104(20):8520–8525. [PubMed]
17. Jiménez-Díaz L., Géranton S.M., Passmore G.M., Leith J.L., Fisher A.S., Berliocchi L., Sivasubramaniam A.K., Sheasby A., Lumb B.M., Hunt S.P. Local translation in primary afferent fibers regulates nociception. PLoS One. 2008;3(4):e1961. [PMC free article] [PubMed]
18. Johnsson N, Weber K. Alkylation of cysteine 82 of p11 abolishes the complex formation with the tyrosine-protein kinase substrate p36 (annexin 2, calpactin 2, lipocortin 2) J. Biol. Chem. 1990;265:14464–14468. [PubMed]
19. Johnsson N., Marriott G., Weber K. p36, the major cytoplasmic substrate of src tyrosine protein kinase, binds to its p11 regulatory subunit via a short amino-terminal amphipathic helix. EMBO J. 1988;7(8):2435–2442. [PubMed]
20. Jost M., Gerke V. Mapping of a regulatory important site for protein kinase C phosphorylation in the N-terminal domain of annexin II. Biochim. Biophys. Acta. 1996;1313(3):283–289. [PubMed]
21. Kazarinova-Noyes K., Malhotra J.D., McEwen D.P., Mattei L.N., Berglund E.O., Ranscht B., Levinson S.R., Schachner M., Shrager P., Isom L.L., Xiao Z.C. Contactin associates with Na+ channels and increases their functional expression. J. Neurosci. 2001;21(19):7517–7525. [PubMed]
22. Kim E., Sheng M. PDZ domain proteins of synapses. Nat. Rev. Neurosci. 2004;5(10):771–781. [PubMed]
23. König J., Prenen J., Nilius B., Gerke V. The annexin II–p11 complex is involved in regulated exocytosis in bovine pulmonary artery endothelial cells. J. Biol. Chem. 1998;273(31):19679–19684. [PubMed]
24. Lai J., Gold M.S., Kim C.S., Bian D., Ossipov M.H., Hunter J.C., Porreca F. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel NaV1.8. Pain. 2002;95(1–2):143–152. [PubMed]
25. Lin C.R., Amaya F., Barrett L., Wang H., Takada J., Samad T.A., Woolf C.J. Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity. J. Pharmacol. Exp. Ther. 2006;319(3):1096–1103. [PubMed]
26. Liu C., Cummins T.R., Tyrrell L., Black J.A., Waxman S.G., Dib-Hajj S.D. AP-1A is a novel linker that binds clathrin and the voltage-gated sodium channel Na(v)1.8. Mol. Cell. Neurosci. 2005;28(4):636–649. [PubMed]
27. Liu C., Li Q., Su Y., Bao L. Prostaglandin E2 promotes Nav1.8 trafficking via its intracellular RRR motif through the protein kinase A pathway. Traffic. 2010;11(3):405–417. [PubMed]
28. McEwen D.P., Meadows l.S., Chen C., Thyagarajan V., Isom L.L. Sodium channel beta1 subunit-mediated modulation of Nav1.2 currents and cell surface density is dependent on interactions with contactin and ankyrin. J. Biol. Chem. 2004;279(16):16044–16049. [PubMed]
29. Macara I.G., Iioka H., Mili S. Axon growth-stimulus package includes local translation. Nat. Cell. Biol. 2009;11(8):919–921. [PMC free article] [PubMed]
30. Malik-Hall M., Poon W.-Y.L., Baker M.D., Wood J.D., Okuse K. Sensory neuron proteins interact with the intracellular domains of sodium channel NaV1.8. Brain Res. Mol. Brain Res. 2003;110(2):298–304. [PubMed]
31. Okuse K. Pain signalling pathways: from cytokines to ion channels. Int. J. Biochem. Cell Biol. 2007;39(3):490–496. [PubMed]
32. Okuse K., Malik-Hall M., Baker M.D., Poon W.-Y.L., Kong H., Chao M.V., Wood J.N. Annexin II light chain regulates sensory neuron-specific sodium channel expression. Nature. 2002;417(6889):653–656. [PubMed]
33. Poon W.-Y.L., Malik-Hall M., Wood J.N., Okuse K. Identification of binding domains in the sodium channel Na(V)1.8 intracellular N-terminal region and annexin II light chain p11. FEBS Lett. 2004;558(1–3):114–118. [PubMed]
34. Rescher U., Gerke V. S100A10/p11: family, friends and functions. Pflugers Arch. 2008;455(4):575–582. [PubMed]
35. Renigunta V., Yuan H., Zuzarte M., Rinné S., Koch A., Wischmeyer E., Schlichthörl G., Gao Y., Karschin A., Jacob R., Schwappach B., Daut J., Preisig-Müller R. The retention factor p11 confers an endoplasmic reticulum-localization signal to the potassium channel TASK-1. Traffic. 2006;7(2):168–181. [PubMed]
36. Ritchie J.M., Black J.A., Waxman S.G., Angelides K.J. Sodium channels in the cytoplasm of Schwann Cells. Proc. Natl. Acad. Sci. U. S. A. 1990;87:9290–9294. [PubMed]
37. Rush A.M., Craner M.J., Kageyama T., Dib-Hajj S.D., Waxman S.G., Ranscht B. Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons. Eur. J. Neurosci. 2005;22(1):39–49. [PubMed]
38. Saris C.J., Kristensen T., D’Eustachio P., Hicks L.J., Noonan D.J., Hunter T., Tack B.F. cDNA sequence and tissue distribution of the mRNA for bovine and murine p11, the S100-related light chain of the protein-tyrosine kinase substrate p36 (Calpactin I) J. Biol. Chem. 1987;262:10663–10671. [PubMed]
39. Schmidt J.W, Catterall W.A. Biosynthesis and processing of the alpha subunit of the voltage-sensitive sodium channel in rat brain neurons. Cell. 1986;46(3):437–444. [PubMed]
40. Scott D.B., Blanpied T.A., Swanson G.T., Zhang C., Ehlers M.D. An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing. J. Neurosci. 2001;21(9):3063–3072. [PubMed]
41. Shah B.S., Stevens E.B., Gonzalez M.I., Bramwell S., Pinnock R.D., Lee K., Dixon A.K. Beta3, a novel auxiliary subunit for the voltage-gated sodium channel, is expressed preferentially in sensory neurons and is upregulated in the chronic constriction injury model of neuropathic pain. Eur. J. Neurosci. 2000;12(11):3985–3990. [PubMed]
42. Shah B.S., Gonzalez M.I., Bramwell S., Pinnock R.D., Lee K., Dixon A.K. Beta3, a novel auxiliary subunit for the voltage gated sodium channel is upregulated in sensory neurones following streptozocin induced diabetic neuropathy in rat. Neurosci. Lett. 2001;309(1):1–4. [PubMed]
43. Shah B.S., Rush A.M., Liu S., Tyrrell L., Black J.A., Dib-Hajj S.D., Waxman S.G. Contactin associates with sodium channel Nav1.3 in native tissues and increases channel density at the cell surface. J. Neurosci. 2004;24(33):7387–7399. [PubMed]
44. Shao D., Baker M.D., Abrahamsen B., Rugiero F., Malik-Hall M., Poon W.-Y.L., Cheah K.S., Yao K.M., Wood J.N., Okuse K. A multi PDZ-domain protein Pdzd2 contributes to functional expression of sensory neuron-specific sodium channel Na(V)1.8. Mol. Cell Neurosci. 2009;42(3):219–225. [PMC free article] [PubMed]
45. Shao D., Okuse K., Djamgoz M.B. Protein–protein interactions involving voltage-gated sodium channels: Post-translational regulation, intracellular trafficking and functional expression. Int. J. Biochem. Cell Biol. 2009;41(7):1471–1481. [PubMed]
46. Smith W.B., Starck S.R., Roberts R.W., Schuman E.M. Dopaminergic stimulation of local protein synthesis enhances surface expression of GluR1 and synaptic transmission in hippocampal neurons. Neuron. 2005;45(5):765–779. [PubMed]
47. Storey N., Latchman D., Bevan S. Selective internalization of sodium channels in rat dorsal root ganglion neurons infected with herpes simplex virus-1. J. Cell Biol. 2002;158(7):1251–1262. [PMC free article] [PubMed]
48. Takahashi N., Kikuchi S., Dai Y., Kobayashi K., Fukuoka T., Noguchi K. Expression of auxiliary beta subunits of sodium channels in primary afferent neurons and the effect of nerve injury. Neuroscience. 2003;121(2):441–450. [PubMed]
49. Taylor C.P. Mechanisms of analgesia by gabapentin and pregabalin--calcium channel alpha2-delta [Cavalpha2-delta] ligands. Pain. 2009;142(1–2):13–16. [PubMed]
50. Thakor D.K., Lin A., Matsuka Y., Meyer E.M., Ruangsri S., Nishimura I., Spigelman I. Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy. Mol. Pain. 2009;5:14. [PMC free article] [PubMed]
51. Wang D.O., Kim S.M., Zhao Y., Hwang H., Miura S.K., Sossin W.S., Martin K.C. Synapse- and stimulus-specific local translation during long-term neuronal plasticity. Science. 2009;324(5934):1534–1536. [PMC free article] [PubMed]
52. Yeung M.L., Tam T.S., Tsang A.C., Yao K.M. Proteolytic cleavage of PDZD2 generates a secreted peptide containing two PDZ domains. EMBO Rep. 2003;4(4):412–418. [PubMed]
53. Zerangue N., Schwappach B., Jan Y.N., Jan L.Y. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron. 1999;22(3):537–548. [PubMed]
54. Zhang Z.N., Li Q., Liu C., Wang H.B., Wang Q., Bao L. The voltage-gated Na+ channel Nav1.8 contains an ER-retention/retrieval signal antagonized by the beta3 subunit. J. Cell Sci. 2008;121(Pt 19):3243–3252. [PubMed]
55. Zimmer D.B., Chaplin J., Baldwin A., Rast M. S100-mediated signal transduction in the nervous system and neurological diseases. Cell. Mol. Biol. 2005;51(2):201–214. [PubMed]